PL380663A1 - Amorficzne postaci rizedronianu monosodowego - Google Patents

Amorficzne postaci rizedronianu monosodowego

Info

Publication number: PL380663A1
Authority: PL; Poland
Prior art keywords: amorphous forms; risedronate monosodium; risedronate; monosodium; amorphous
Prior art date: 2004-02-26

Application number

PL380663A

Other languages

English (en)

Other versions

PL213481B1 (pl

Inventor

Jindrich Richter

Josef Jirman

Hana Petrickova

Original Assignee

Zentiva, A.S.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-26

Filing date

2005-02-28

Publication date

2007-02-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34915827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL380663(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-26 Priority claimed from CZ20040292A external-priority patent/CZ298383B6/cs

2004-07-08 Priority claimed from CZ20040798A external-priority patent/CZ298328B6/cs

2004-08-12 Priority claimed from CZ20040880A external-priority patent/CZ298491B6/cs

2005-02-28 Application filed by Zentiva, A.S. filed Critical Zentiva, A.S.

2007-02-19 Publication of PL380663A1 publication Critical patent/PL380663A1/pl

2013-03-29 Publication of PL213481B1 publication Critical patent/PL213481B1/pl

Links

DRFDPXKCEWYIAW-UHFFFAOYSA-M Risedronate sodium Chemical compound [Na+].OP(=O)(O)C(P(O)([O-])=O)(O)CC1=CC=CN=C1 DRFDPXKCEWYIAW-UHFFFAOYSA-M 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Physical Education & Sports Medicine (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL380663A 2004-02-26 2005-02-28 Amorficzne postaci rizedronianu monosodowego, sposób wytwarzania i preparat farmaceutyczny PL213481B1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CZ20040292A CZ298383B6 (cs)	2004-02-26	2004-02-26	Amorfní forma risedronátu monosodného
CZ20040798A CZ298328B6 (cs)	2004-07-08	2004-07-08	Semikrystalická forma risedronátu monosodného, zpusob jeho prípravy a léková forma ho obsahující
CZ20040880A CZ298491B6 (cs)	2004-08-12	2004-08-12	Zpusob prípravy amorfní formy risedronátu monosodného

Publications (2)

Publication Number	Publication Date
PL380663A1 true PL380663A1 (pl)	2007-02-19
PL213481B1 PL213481B1 (pl)	2013-03-29

Family

ID=34915827

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL05706666T PL1723157T5 (pl)	2004-02-26	2005-02-28	Amorficzne postaci rizedronianu monosodowego
PL380663A PL213481B1 (pl)	2004-02-26	2005-02-28	Amorficzne postaci rizedronianu monosodowego, sposób wytwarzania i preparat farmaceutyczny

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL05706666T PL1723157T5 (pl)	2004-02-26	2005-02-28	Amorficzne postaci rizedronianu monosodowego

Country Status (8)

Country	Link
US (1)	US7618953B2 (pl)
EP (1)	EP1723157B2 (pl)
DE (1)	DE602005003557D1 (pl)
EA (1)	EA009737B1 (pl)
PL (2)	PL1723157T5 (pl)
SK (1)	SK50782006A3 (pl)
UA (1)	UA83900C2 (pl)
WO (1)	WO2005082915A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE602005001873T2 (de)	2004-03-03	2008-04-24	Chemi S.P.A., Cinisello Balsamo	Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
JP2008514722A (ja) *	2004-09-30	2008-05-08	ドクターレディズラボラトリーズリミテッド	非結晶性アトルバスタチンカルシウム
US7872144B2 (en) *	2005-06-13	2011-01-18	Jubilant Organosys Limited	Process for producing biphosphonic acids and forms thereof
GB0519891D0 (en) *	2005-09-30	2005-11-09	Pliva Hrvatska D O O	Pharmaceutically acceptable salts and hydrates
JP5354858B2 (ja) *	2006-05-09	2013-11-27	株式会社Ａｄｅｋａ	スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
JP2009536639A (ja)	2006-05-11	2009-10-15	アイエヌディー−スイフトラボラトリーズリミテッド	純リセドロン酸または塩を調製するための方法
KR100775440B1 (ko) *	2006-12-20	2007-11-12	동우신테크 주식회사	리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
DE102007030370A1 (de)	2007-06-29	2009-01-02	Ratiopharm Gmbh	Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese
KR101010062B1 (ko)	2008-04-11	2011-01-21	주식회사 대희화학	증발 결정화를 이용한 결정상 리세드로네이트 모노소듐모노하이드레이트의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1378234A1 (en) †	1996-05-17	2004-01-07	MERCK & CO. INC.	Effervescent bisphosphonate formulation
KR19990001564A (ko) †	1997-06-16	1999-01-15	유충식	용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
CN1202828C (zh) †	1999-05-21	2005-05-25	诺瓦提斯公司	二膦酸在制备抑制或逆转血管发生的药物中的用途
PE20011061A1 (es) *	2000-02-01	2001-11-20	Procter & Gamble	Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
GB2383042A (en) †	2001-10-18	2003-06-18	Cipla Ltd	Amorphous alendronate sodium
HRP20041051A2 (en) †	2002-04-11	2005-02-28	Teva Pharmaceutical Industries Ltd.	Novel polymorphs and pseudopolymorphs of risedronate sodium
CZ293349B6 (cs)	2002-10-25	2004-04-14	Léčiva, A.S.	Nová krystalická forma sodné soli kyseliny 3-pyridyl-1-hydroxyethyliden-1,1-bisfosfonové
CZ298639B6 (cs) †	2004-02-05	2007-12-05	Zentiva, A. S.	Krystalická forma risedronátu monosodného
DE602005001873T2 (de) †	2004-03-03	2008-04-24	Chemi S.P.A., Cinisello Balsamo	Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
US7872144B2 (en) †	2005-06-13	2011-01-18	Jubilant Organosys Limited	Process for producing biphosphonic acids and forms thereof

2005
- 2005-02-28 US US10/590,694 patent/US7618953B2/en not_active Expired - Lifetime
- 2005-02-28 PL PL05706666T patent/PL1723157T5/pl unknown
- 2005-02-28 PL PL380663A patent/PL213481B1/pl unknown
- 2005-02-28 SK SK5078-2006A patent/SK50782006A3/sk not_active Application Discontinuation
- 2005-02-28 EA EA200601438A patent/EA009737B1/ru not_active IP Right Cessation
- 2005-02-28 UA UAA200610284A patent/UA83900C2/ru unknown
- 2005-02-28 EP EP05706666.4A patent/EP1723157B2/en not_active Expired - Lifetime
- 2005-02-28 DE DE602005003557T patent/DE602005003557D1/de not_active Expired - Lifetime
- 2005-02-28 WO PCT/CZ2005/000024 patent/WO2005082915A1/en not_active Ceased

Also Published As

Publication number	Publication date
PL1723157T5 (pl)	2018-01-31
US20070142332A1 (en)	2007-06-21
EA009737B1 (ru)	2008-02-28
EP1723157A1 (en)	2006-11-22
UA83900C2 (en)	2008-08-26
EP1723157B1 (en)	2007-11-28
EP1723157B2 (en)	2017-02-08
EA200601438A1 (ru)	2006-12-29
WO2005082915A1 (en)	2005-09-09
PL1723157T3 (pl)	2008-04-30
US7618953B2 (en)	2009-11-17
PL213481B1 (pl)	2013-03-29
DE602005003557D1 (de)	2008-01-10
SK50782006A3 (sk)	2007-03-01

Publication	Publication Date	Title
IL268462A (en)	2019-09-26	Dosage form of risedronate
IL179020A0 (en)	2007-03-08	Compounds for enzyme inhibition
IL176416A0 (en)	2006-10-05	Prostaglandin nitrooxyderivatives
IL180358A0 (en)	2007-06-03	Crystalline form iv of linezolid
ZA200904053B (en)	2010-04-28	Phosphonate compounds
IL185757A0 (en)	2008-01-06	Methods of decreasing calcifcation
ZA200706170B (en)	2008-09-25	Ibandronate polymorph B
IL183380A0 (en)	2007-09-20	Crystalline forms of linezolid intermediate
IL197327A0 (en)	2009-12-24	Crystalline rosuvastatin calcium
ZA200903614B (en)	2010-03-31	New crystalline forms
IL190082A0 (en)	2008-11-03	Novel multi-cyclic compounds
PL1723157T3 (pl)	2008-04-30	Amorficzne postaci rizedronianu monosodowego
IL195061A0 (en)	2009-08-03	Crystalline forms of atorvastatin
IL208214A0 (en)	2010-12-30	Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
ZA200806859B (en)	2009-08-26	Novel crystalline compounds
SI1745064T1 (sl)	2011-05-31	Spojine za inhibiranje proteasomskega encima
EP2100574A4 (en)	2009-12-30	AESTHETIC CORRECTION
GB2437917B (en)	2009-05-20	Walking aid
EE00444U1 (et)	2004-07-15	Fosforiühend
EP1744627A4 (en)	2011-10-26	COMPOSITION FOR THE CONTROL OF COFFEE
GB0417878D0 (en)	2004-09-15	Manufacture of boxes
PL379138A1 (pl)	2007-09-17	Kompozycja fotopolimeryzująca
GB0526010D0 (en)	2006-02-01	Phosphorus compounds
GB0622798D0 (en)	2006-12-27	Phosphorus compounds
PL374474A1 (pl)	2006-10-30	Sposób wytwarzania hemipentahydratu rizedronianu sodu